See MatTek at World Preclinical Congress 2017 in Boston, MA
MatTek is pleased to announce its attendance at the 16th Annual World Preclinical Congress, June 12 through June 16, 2017, in Boston, MA. World Preclinical Congress is an essential scientific and networking event yielding new partnerships that accelerate preclinical research and translation across all therapeutic areas. It offers a unique opportunity for leading scientists and executives from industry and academia as well as technology providers to come together and exchange expertise and opinions in the areas of disease modeling, drug metabolism and toxicity, target ID and validation, preclinical immuno-oncology, translational CNS research and more. MatTek will be at Booth 505 and host a talk on the EpiIntestinal model, led by Dr. Seyoum Ayehunie. The talk will discuss how 3D organotypic tissue models are changing the landscape of preclinical testing; specifically EpiIntestinal’s ability for predicting adverse drug reactions.
Visit us at Booth #505
Join us for a talk on how 3DÂ models are changing preclinical testing, featuring our own Dr. Seyoum Ayehunie:
Organotypic Small Intestinal Tissue Model for Prediction of Adverse Drug Reactions
Tuesday, June 13, 9:35 am – 10:05 am
Abstract:
Gastrointestinal adverse drug reactions (ADR) cause health problems and create a burden on the health care system and the pharmaceutical industry. Gastrointestinal ADR often leads to late-stage drug attrition. In this presentation, we will demonstrate the utility of a novel in vitro 3D primary human small intestine based system to identify biomarkers that can better predict human ADR compared to preclinical animal models and is ideal for therapeutic candidate screening.
For more information on the meeting and its events, visit the World Preclinical Congress website.
